News

AddToAny

Google+ Facebook Twitter Twitter

Bacteria provoke “warfare”

Some bacteria can release toxins that provoke their neighbours into attacking each other, says a new study.

Bacteria Warfare

The authors state that this is a tactic that could be exploited to fight infections.

Bacteria often engage in “warfare” by releasing toxins or other molecules that damage or kill competing strains.

This war for resources occurs in most bacterial communities, such as those living naturally in our gut, or those that cause infection.

As well as producing toxins that directly kill their competitors, bacteria can release toxin “provoking agents” that make other strains increase their aggression levels by boosting their toxic response.

In a new study, led by Imperial College London and the University of Oxford, researchers used a combination of experiments and mathematical models to see what happens when bacteria provoke their competitors.

When used against a single competitor, they found that provocation backfires: the provoked strain mounts a strong toxic counter-attack and harms the provoking strain. When three or more strains are present, provocation causes competing strains to increase their aggression and attack each other. This can lead to the competitors wiping each other out, especially when the provoking strain is shielded from, or resistant to, their toxins.

Lead author Diego Gonzalez said: “By provoking other strains to attack each other, the toxin of the provoker is more effective than what would be expected based on its real toxicity.”  

bit.ly/BS_AugNews05

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top